Physician
He, Zili
He, Zili was paid $849K by Medicaid between Mar 2018 and Dec 2024, across 48 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoHE, ZILI
FLUSHING, NY 11355
FLUSHING, NY 11355
33aNPI1598709388assigned 06/15/2006
33bProvider typeHematology & Oncology Physician
28Total paid$849K
24GClaims56,768
24DCodes billed48
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in New York
Rank by total paid#17 of 441
Median peer was paid$9K
This provider vs. median90×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 811 | $11K | |
| 2019 | 5,514 | $83K | |
| 2020 | 6,313 | $105K | |
| 2021 | 9,403 | $161K | |
| 2022 | 12,236 | $174K | |
| 2023 | 11,156 | $161K | |
| 2024incomplete | 11,335 | $156K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 12,125 | 8,612 | $322K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 2,915 | 2,851 | $127K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 13% | 3,195 | 1,739 | $109K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.9% | 4,795 | 1,939 | $67K |
| 96367 | 5.0% | 2,620 | 1,360 | $43K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.5% | 779 | 771 | $38K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 746 | 367 | $25K |
| Q0084 | Chemotherapy administration by infusion technique only, per visit | 1.8% | 598 | 343 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 3,752 | 2,143 | $15K |
| 96417 | 1.4% | 320 | 200 | $12K | |
| 99205 | Prolong outpt/office vis | 1.3% | 183 | 180 | $11K |
| 96415 | 1.2% | 660 | 380 | $10K |
36 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 6,424 | $10K |
| 96401 | 1.1% | 420 | $10K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.0% | 1,525 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 836 | $7K |
| 36593 | <1% | 645 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 265 | $3K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 375 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,307 | $2K |
| 96416 | <1% | 22 | $2K | |
| Q0081 | Infusion therapy, using other than chemotherapeutic drugs, per visit | <1% | 201 | $2K |
| 96522 | <1% | 42 | $1K | |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 1,591 | $1K |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | <1% | 688 | $845.04 |
| 99195 | <1% | 33 | $699.37 | |
| 96411 | <1% | 21 | $569.80 | |
| 99442 | <1% | 16 | $362.02 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,524 | $289.87 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,320 | $192.14 |
| 96523 | <1% | 91 | $52.55 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 26 | $35.14 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 52 | $28.80 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 22 | $21.61 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 104 | $11.26 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 378 | $5.09 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 146 | $0.40 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 130 | $0.00 |
| 1126F | 0% | 138 | $0.00 | |
| 3074F | 0% | 73 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 36 | $0.00 |
| 1036F | 0% | 136 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 12 | $0.00 |
| 3288F | 0% | 138 | $0.00 | |
| 3078F | 0% | 96 | $0.00 | |
| 1494F | 0% | 138 | $0.00 | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 0% | 23 | $0.00 |
| 99080 | 0% | 86 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.